Results 31 to 40 of about 4,557 (175)
Androgenetic alopecia: An update
Androgenetic alopecia (AGA) is one of the commonest reasons for dermatological consultation. Over the last few years our understanding of the pathophysiology of AGA has improved and this has paved way for better diagnostic and therapeutic options.
Feroze, Kaliyadan +2 more
openaire +2 more sources
Androgenetic Alopecia in Women [PDF]
Androgenetic alopecia (AGA), also known in women as female pattern hair loss, is caused by androgens in genetically susceptible women and men. The thinning begins between ages 12 and 40 years, the inheritance pattern is polygenic, and the incidence is the same as in men. In susceptible hair follicles, dihydrotestosterone binds to the androgen receptor,
openaire +2 more sources
ABSTRACT Background There is a growing body of literature suggesting that GLP‐1 receptor agonists (GLP‐1RAs) may be associated with hair loss; however, primary literature is sparse. Additionally, it is not well‐established which types of hair loss may be associated with GLP‐1RA use. Objectives This study aims to assess associations between GLP‐1RAs and
Lauren M. Ching +2 more
wiley +1 more source
Pharmacotherapy of androgenetic alopecia – a literature review
INTRODUCTION: Androgenetic alopecia, also known as male pattern baldness, is a common dermatological problem. It manifests as hair thinning and miniaturization of hair follicles. In recent years, knowledge of the risk factors and pathomechanisms of this
Marcin Tyszkiewicz +3 more
doaj +1 more source
Since the results of basic and specific classification in male androgenetic alopecia are subjective, and trichoscopic data, such as hair density and diameter distribution, are potential quantitative indicators, the aim of this study was to develop a deep
Meng Gao +9 more
doaj +1 more source
Recent progress on the development of hydrogel‐based microneedles for transdermal drug delivery
This study provides a comprehensive and up‐to‐date analysis of recent progress in HMN technology, covering fundamental transdermal delivery mechanisms and design principles, biomaterials used in HMN fabrication, drug loading and release strategies, and emerging therapeutic applications.
Mohammad Muhtasim Ittisaf +5 more
wiley +1 more source
Background and Aims Androgenetic alopecia is the most common cause of hair loss in both men and women. The aim of this case‐control study was to investigate the role of phenotype (hair shape, thickness, and color) and demographic characteristics ...
Afsaneh Sadeghzadeh Bazargan +6 more
doaj +1 more source
Androgenetic alopecia is one of the most common dermatologic disorders in the daily clinical practice of dermatologists. Despite it is such a common entity, few medications are FDA‐approved for its treatment.
Miguel Dominguez‐Santas +11 more
doaj +1 more source
The Effect of topical Minoxidil in Treatment of androgenetic Alopecia [PDF]
Androgenetic alopecia (AGA) is characterized by a non-scarring progressive miniaturization of the hair follicle in predisposed men and women with a pattern distribution. Although AGA is a very prevalent condition, approved therapeutic options are limited.
Rasha A. +4 more
doaj +1 more source
Segmental Pallor and Hair Loss in a Patient With Ross Syndrome: Case Report
ABSTRACT A 30‐year‐old male sought medical consultation due to sudden anisocoria. Clinical examination confirmed Adie's tonic pupil. Subsequently, the presence of segmental anhidrosis with compensatory hyperhidrosis and areflexia established the diagnosis of Ross syndrome.
Markus Augusto Martínez Holst +5 more
wiley +1 more source

